Avalo Therapeutics, Inc. (AVTX) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Avalo Therapeutics, Inc. (AVTX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $224.2M, listed on NASDAQ, employing roughly 23 people, carrying a beta of 0.79 to the broader market. Avalo Therapeutics, Inc. Led by Garry A. Neil, public since 2015-10-14.
Snapshot as of May 15, 2026.
- Spot Price
- $17.52
- Total OI
- 109.3K